"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
| Descriptor ID |
D006258
|
| MeSH Number(s) |
C04.588.443
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".
This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.
-
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. Int J Mol Sci. 2023 Mar 14; 24(6).
-
Patient-Reported Outcomes Integrated Within an Electronic Medical Record in Patients With Head and Neck Cancer. JCO Clin Cancer Inform. 2021 08; 5:842-848.
-
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors. Eur J Med Chem. 2021 Feb 05; 211:113095.
-
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy. Radiother Oncol. 2020 10; 151:182-189.
-
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy. Radiother Oncol. 2018 12; 129(3):575-581.
-
Clonal expansion of different mtDNA variants without selective advantage in solid tumors. Mutat Res. 2009 Mar 09; 662(1-2):28-32.
-
Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study. J Toxicol Environ Health A. 2008; 71(11-12):803-15.
MeSH information
